Exome capture and DNA sequencing of 316 high-grade serous adenocarcinomas, however, did not identify any mutations in RAD51D, although 20% of tumours carried a germline or somatic mutation in BRCA1 or BRCA2 (Cancer Genome Atlas Research Network, 2011). Here, RAD51D is linked to serous adenocarcinoma.